Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals.
Willems
F
F
Hôpital Erasme, Bruxelles, Belgium.
Andris
F
F
Abramowicz
D
D
Piérard
G
G
Wissing
M
M
Leo
O
O
Goldman
M
M
D002478:Cells, Cultured; D017635:Clonal Anergy; D016572:Cyclosporine / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis*; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D007700:Kinetics; D008213:Lymphocyte Activation / Q000187:drug effects; D016853:Muromonab-CD3 / Q000494:pharmacology*; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D016207:Cytokines; D007376:Interleukin-2; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell; D016753:Interleukin-10; D007371:Interferon-gamma; D016572:Cyclosporine